Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria

Rheumatology (Oxford). 2019 Dec 1;58(12):2331-2333. doi: 10.1093/rheumatology/kez253.

Fergus To¹, Matthew J S Parker^{2

3}, Clara Ventín-Rodríguez⁴, James B Lilleker^{5

6}, Hector Chinoy^{7

8}

¹ Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada.
² Department of Rheumatology, Institute of Rheumatology and Orthopaedics, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia.
³ University of Sydney, Camperdown, Sydney, NSW, Australia.
⁴ Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
⁵ Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
⁶ Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.
⁷ National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester, Manchester, UK.
⁸ Department of Rheumatology, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK.

No abstract available

Publication types